tiprankstipranks
Galera Therapeutics expects cash to fund operations into 2H23
The Fly

Galera Therapeutics expects cash to fund operations into 2H23

As of September 30, 2022, Galera had cash, cash equivalents and short-term investments of $42.8 million. Galera expects that its existing cash, cash equivalents and short-term investments will enable Galera to fund its operating expenses and capital expenditure requirements into the second half of 2023.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on GRTX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles